Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Scripps Translational Science Institute
AddedFeb 17, 2024
UpdatedJun 18, 2026
Scripps Translational Science Institute

Scripps Translational Science Institute

Series C

LA-based Scripps Translational Science Institute pioneers genomic advances into diagnostics and treatments, with a focus on lifestyle changes.

HQ
Los Angeles, CA, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Founded in Los Angeles, California, the Scripps Translational Science Institute (STSI) aims to innovate, transform, and fully integrate clinical and translational research. The institute focuses on translating genomic advances into new diagnostics and treatments, emphasizing lifestyle changes to improve health outcomes. STSI collaborates with Scripps Genomic Medicine to build a comprehensive human DNA bank, which aids in identifying genetic markers for various diseases, including cardiovascular conditions and cancers.

Notable affiliated individuals include Sarah S. Murray, Ph.D., Director of Genetics, and Todd Herrell, IT Site Coordinator. STSI has partnered with prominent organizations such as Affymetrix, Microsoft, and Navigenics. Key achievements include presenting the HOPE Act to President Obama for signature. The institute's work has significantly impacted the field of genomics, contributing to the development of personalized medicine and advancing the understanding of genetic influences on health.

Scripps Translational Science Institute - Quick Facts

When was Scripps Translational Science Institute founded?

Scripps Translational Science Institute was founded in 2006.

Where is Scripps Translational Science Institute's headquarters located?

Scripps Translational Science Institute's headquarters is located in Los Angeles, CA, US.

When was Scripps Translational Science Institute's last funding round?

Scripps Translational Science Institute's most recent funding round was for $34M (USD) in May 2018.

How much has Scripps Translational Science Institute raised to-date?

As of May 2, 2018, Scripps Translational Science Institute has raised a total of $34M (USD).

How many employees does Scripps Translational Science Institute have?

Scripps Translational Science Institute has 31 employees as of Feb 4, 2024.

Classification

Technology
  • Genomics
Customer
  • Non-Profit
Main Product
  • Genomic Research
Tags
  • Biotech
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 14 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 621000Ambulatory Health Care Services
  • 621400Outpatient Care Centers
  • 621490Other Outpatient Care Centers
  • 621491HMO Medical Centers
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8010Offices And Clinics Of Doctors Of Medicine
  • 8011Offices And Clinics Of Doctors Of Medicine
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research